PR

Proteon Therapeutics

- NASDAQ:PRTO
Last Updated 2020-10-30
  • Proteon Therapeutics is a biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases.

  • Locations

    • Waltham MA

  • Total Funding (USD)

    107.0 million

  • Industries

    Software, Mobile Apps, Video Games, Cyber Security, Real Estate, Internet

  • Security

    Type: ORD
    CUSIP: 74365U107
    ISIN: US74365U1079
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo